The Global Parkinson’s disease therapeutics market is accelerating into a new era of scientific possibility and patient-centered innovation, with total valuation projected to climb from USD 5.46 Billion in 2023 to USD 10.12 Billion by 2032-a compound annual growth rate (CAGR) of 7.1% over the forecast period. This sustained expansion is driven by the rapidly aging global population,...

Introspective Market Research Projects Global Ceftriaxone Sodium Market to Grow at ~3.09% CAGR Through 2032, Driven by Rising Infectious Diseases, Hospital Demand & Evolving Therapeutic Needs Introspective Market Research today published its detailed forecast for the global Ceftriaxone Sodium market. According to the report (Report ID: 11656), the market was valued at approximately USD 1.86...